Although several different cytogenetic classifications exist for acute myeloid leukemia (AML), it has been generally agreed that specific cytogenetic abnormalities result in unfavorable prognoses.

Ten DNA samples from BM and PB of patients 1, 5, 8, 9, 10 and 12 were used to assess the proportion of cells with monosomy 7 by our newly developed RQ-PCR method. The DNA was from the same cells used ...

Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk ...

Decitabine therapy for myeloproliferative neoplasm in accelerated (MPN-AP) or blastic (acute myeloid leukemia; MPN-AML) phase. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I.